MedPath

Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic

Not Applicable
Completed
Conditions
Obesity
Interventions
Other: TOPS
Registration Number
NCT03202420
Lead Sponsor
Duke University
Brief Summary

The purpose of this pilot proposal are the following: 1) to determine the feasibility and acceptability of integrating the TOPS weight loss program into underserved populations through an urban safety net clinic and 2) to gather preliminary data of weight change to inform the design of a future randomized, controlled trial to determine the efficacy of the TOPS program in safety net clinics.

To achieve these goals, the investigators will pursue the following Specific Aims:

Specific Aim 1. Assess the feasibility and acceptability of integrating the TOPS program into an urban safety net clinic, with process measures (i.e., recruitment/refusal rates and retention/dropout rates) and focus groups.

Hypothesis 1. Integrating the TOPS program into an urban safety net clinic is feasible and acceptable to participants.

Specific Aim 2. Assess the percent of participants in the TOPS intervention arm with clinically significant weight change (i.e., weight loss of ≥5% of initial body weight) at 12, 26, and 52 weeks.

Hypothesis 2. 10%, 25%, and 33% of participants in the TOPS intervention arm will lose ≥5% of initial body weight at 12, 26, and 52 weeks, respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
26
Inclusion Criteria
  • Participants must be patients of the DOC.
  • BMI: Asian patients with a BMI of ≥23 kg/m2 and patients of other racial and ethnic backgrounds will be included if have a BMI of ≥25 kg/m2. Asian patients are allowed to participate at a BMI in the normal range because they are more likely to develop diabetes (or insulin resistance or glucose intolerance at a BMI of 23 kg/m2).
Read More
Exclusion Criteria
  • Mental illness that would cause disruptions to group meetings
  • Cognitive impairment that would preclude participants from understanding the program
  • Type 2 diabetics on insulin or sulfonylureas without provider approval
  • untreated hyper- or hypothyroidism
  • current cancer diagnosis
  • history of cancer (other than skin cancer)
  • gastrointestinal disorders affecting food intake
  • use of medications thought to effect metabolism, body weight, energy expenditure, or appetite
  • women currently pregnant or lactating, planning to become pregnant, or less than 6 months post-partum
  • weight loss of > 5% in past 6 months
  • major psychiatric disorder
  • current moderate to severe symptoms of depression
  • eating disorders
  • current alcohol or substance abuse.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TOPSTOPSParticipants will attend weekly TOPS meetings with standard weekly weigh ins
Primary Outcome Measures
NameTimeMethod
Change in WeightBaseline, 12, 24, and 52 weeks

Weekly weight data will be collected by the DOC Designee at baseline, 12, 24, and 52 weeks.

Secondary Outcome Measures
NameTimeMethod
Retention as measured by attendance sheets12, 24 and 52 weeks

Calculate the retention of participants in the TOPS at DOC program at 12, 24, and 52 weeks.

Program Attendance52 Weeks

Calculate the percentage of TOPS at DOC group session attendance (sessions attended/total offered).

Trial Locations

Locations (1)

Duke General Internal Medicine

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath